Business
Voyageur Pharmaceuticals Ltd. Announces Issuance of Shares to Pay for Deposits and Debt
(TheNewswire) News Release – Calgary, Alberta – TheNewswi...
About this update from Voyageur Pharmaceuticals Ltd
[{"type":"text","content":"Voyageur Pharmaceuticals Ltd. Announces Issuance of Shares to Pay for Deposits and Debt\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n News Release – Calgary, Alberta\n–\n \n \n TheNewswire -\n \n \n May 10, 2022:\n \n \n Voyageur Pharmaceuticals Ltd.\n \n \n (TSXV:VM) (USA:VYYRF) (the \"Company\" or\n\"Voyageur\") has agreed to pay deposits for work on design of\nthe Company's manufacturing facility and pay other existing debts in\nan amount of up to $100,000 through the issuance of common shares of\nthe Company (\"Common Shares\") at a deemed price per share of\n$0.11 based on the closing price of the Common Shares at the close of\ntrading on May 10, 2022 (the \"Share Payments\").\n \n \n \n \n The Share Payments are subject to regulatory approval,\nincluding the approval of the TSX Venture Exchange. The Common Shares\nissued pursuant to the Share Payments are subject to a four month hold\nperiod from the date of issuance.\n \n \n \n \n About Voyageur\n \n \n \n \n Voyageur is a Canadian public company listed on the\nTSXV under the trading symbol VM. Voyageur is focused on the\ndevelopment of barite and iodine Active Pharmaceutical Ingredients\n(“API”) and high-performance cost-effective imaging contrast\nagents for the medical radiology marketplace. Voyageur’s goal is to\ninitially generate positive cash flow from operations using third\nparty GMP pharmaceutical manufacturers in Canada and internationally.\nUltimately, Voyageur has plans to build all the required\ninfrastructure to become 100% self-sufficient with all manufacturing.\nVoyageur owns a 100% interest in three barium sulphate (barite)\nprojects including the Frances Creek property, suitable in grade for\nthe pharmaceutical barite marketplace, with interests in a high-grade\niodine, lithium & bromine brine project located in Utah,\nUSA.\n \n \n \n \n Voyageur is moving forward with its business plan of\nbecoming the only fully integrated company in the radiology medical\nfield, by controlling all primary input costs under the motto of:\n\"From the Earth to the Bottle\".\n \n \n \n \n For Further Media\nInformation or to set up an interview, please contact:\n \n \n \n \n \n \n Brent\nWillis\n \n \n \n \n President &\nCEO\n \n \n \n \n E\n \n \n \n \n [email protected]\n \n \n \n \n \n \n \n \n www.voyageurpharmaceuticals...